Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma von Najjar, Yana G, McCurry, Dustin, Lin, Huang, Lin, Yan, Zang, Yan, Davar, Diwakar, Karunamurthy, Arivarasan, Drabick, Joseph J, Neves, Rogerio I, Butterfield, Lisa H, Ernstoff, Marc S, Puzanov, Igor, Skitzki, Joseph J, Bordeaux, Jennifer, Summit, IlaSri B, Bender, Jehovana O, Kim, Ju Young, Chen, Beiru, Sarikonda, Ghanashyam, Pahuja, Anil, Tsau, Jennifer, Alfonso, Zeni, Laing, Christian, Pingpank, James F, Holtzman, Matthew P, Sander, Cindy, Rose, Amy, Zarour, Hassane M, Kirkwood, John M, Tarhini, Ahmad A

Volltext

Neoadjuvant Pembrolizumab and High Dose Interferon Alfa-2b in Resectable Regionally Advanced Melanoma von Najjar, Yana G., McCurry, Dustin, Lin, Huang, Lin, Yan, Zang, Yan, Davar, Diwakar, Karunamurthy, Arivarasan, Drabick, Joseph J., Neves, Rogerio I., Butterfield, Lisa H., Ernstoff, Marc S., Puzanov, Igor, Skitzki, Joseph J., Bordeaux, Jennifer, Summit, IlaSri B., Bender, Jehovana O., Kim, Ju Young, Chen, Beiru, Sarikonda, Ghanashyam, Pahuja, Anil, Tsau, Jennifer, Alfonso, Zeni, Laing, Christian, Pingpank, James F., Holtzman, Matthew P., Sander, Cindy, Rose, Amy, Zarour, Hassane, Kirkwood, John M., Tarhini, Ahmad A.

Volltext

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma von Shiuan, Eileen, Reddy, Anupama, Dudzinski, Stephanie O, Lim, Aaron R, Sugiura, Ayaka, Hongo, Rachel, Young, Kirsten, Liu, Xian-De, Smith, Christof C, O'Neal, Jamye, Dahlman, Kimberly B, McAlister, Renee, Chen, Beiru, Ruma, Kristen, Roscoe, Nathan, Bender, Jehovana, Ward, Joolz, Kim, Ju Young, Vaupel, Christine, Bordeaux, Jennifer, Ganesan, Shridar, Mayer, Tina M, Riedlinger, Gregory M, Vincent, Benjamin G, Davis, Nancy B, Haake, Scott M, Rathmell, Jeffrey C, Jonasch, Eric, Rini, Brian I, Rathmell, W Kimryn, Beckermann, Kathryn E

Volltext